Cell Press Reviews: Cancer Therapeutics informs, inspires, and connects cancer researchers at all stages in their careers with timely, comprehensive reviews written by leaders in the field and curated by Cell Press editors. The publication offers a broad view of some of the most compelling topics in cancer therapeutics including genetic approaches for personal oncology, targeting epigenetic dysregulation and protein interaction networks, vaccines and antibodies in cancer immunotherapy, tumor heterogeneity and chemotherapy resistance, and tumor-associated macrophages in anticancer treatment. Contributions come from leading voices in the field, including Daniel A. Haber, Director of Massachusetts General Hospital Cancer Center and Professor at Harvard Medical School, and Tony Kouzarides, Professor at the University of Cambridge, Deputy Director of the Wellcome Trust/Cancer Research UK Gurdon Institute.